Skip to main content

Page of 2 next disabled
and
  1. No Access

    Article

    Malignes Melanom − Früherkennung, Diagnostik und Nachsorge

    Das maligne Melanom ist eine häufige Hautkrebsart mit einer sehr hohen Mortalität. In Europa versterben jährlich etwa 22.000 Menschen daran, davon etwa 2700 Patienten alleine in Deutschland. Die Inzidenz zeigt...

    Gabor Dobos, Kimberley Farmer, Ralf Gutzmer, Felix Kiecker in Der Onkologe (2018)

  2. No Access

    Article

    The histamine H4 receptor modulates the differentiation process of human monocyte-derived M1 macrophages and the release of CCL4/MIP-1β from fully differentiated M1 macrophages

    Histamine is an important mediator of biological functions and present in high amounts in inflammatory skin lesions which are characterised by a marked infiltration of myeloid derived cell populations. The aim...

    Susanne Mommert, Lisanne Ratz, Holger Stark, Ralf Gutzmer in Inflammation Research (2018)

  3. No Access

    Article

    Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders

    Ipilimumab and programmed death (PD) 1-antibodies are effective treatment options in metastatic melanoma. The safety and efficacy of ipilimumab in patients with pre-existing autoimmune disorders (AD) has only ...

    Katharina C. Kähler, Thomas K. Eigentler in Cancer Immunology, Immunotherapy (2018)

  4. Article

    Open Access

    Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients

    Concomitant radiation with BRAF inhibitor (BRAFi) therapy may increase radiation-induced side effects but also potentially improve tumour control in melanoma patients.

    Markus Hecht, Friedegund Meier, Lisa Zimmer, Bülent Polat in British Journal of Cancer (2018)

  5. Article

    Open Access

    Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions

    Melanoma treatment has been revolutionized by antibody-based immunotherapies. IFNγ secretion by CD8+ T cells is critical for therapy efficacy having anti-proliferative and pro-apoptotic effects on tumour cells. O...

    Antje Sucker, Fang Zhao, Natalia Pieper, Christina Heeke in Nature Communications (2017)

  6. Article

    Open Access

    Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre study

    Aviscumine, a recombinant plant protein, is an immune modulator that induces ribotoxic stress at the 28S ribosomal RNA subunit. In this way cytokine release and T-cell responses are enhanced. This phase II tri...

    Uwe Trefzer, Ralf Gutzmer, Tabea Wilhelm in Journal for ImmunoTherapy of Cancer (2014)

  7. No Access

    Article

    Well characterized antihistamine 4 receptor antibodies contribute to current knowledge of the expression and biology of the human and murine histamine 4 receptor

    Ralf Gutzmer, Thomas Werfel, Wolfgang Bäumer in Naunyn-Schmiedeberg's Archives of Pharmaco… (2012)

  8. No Access

    Article

    The Role of the Histamine H4 Receptor in Atopic Dermatitis

    The pathology of atopic dermatitis is orchestrated on the cellular level by several different cell types in the characteristic skin lesions. In such lesions, histamine as a mediator of many biological function...

    Susanne Mommert, Maria Gschwandtner, Ralf Gutzmer in Current Allergy and Asthma Reports (2011)

  9. No Access

    Article

    Criteria in Sentinel Lymph Nodes of Melanoma Patients that Predict Involvement of Nonsentinel Lymph Nodes

    Previous studies described various criteria in sentinel lymph nodes (SLN) of melanoma patients that predict the involvement of further, nonsentinel lymph nodes (NSLN). Such criteria may facilitate the selectio...

    Imke Satzger, Bernward Völker, Andre Meier, Alexander Kapp in Annals of Surgical Oncology (2008)

  10. No Access

    Article

    15. Mainzer Allergie-Workshop 2003

    Prof. Dr. J. Saloga, Prof. Dr. J. Knop, H. P. Rihs, B. Dumont in Allergo Journal (2003)

  11. No Access

    Article

    Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma

    Mutations of the tumour-suppressor gene NF1 (neurofibromatosis 1) have been observed in neurofibromas and neurofibrosarcomas of patients with von Recklinghausen's disease and in sporadic nerve sheath tumours. In...

    Ralf Gutzmer, Rudolf Herbst, Susanne Mommert, Peter Kiehl, Frank Matiaske in Human Genetics (2000)

  12. No Access

    Article

    Amikrobielle intertriginöse Pustulose bei Autoimmunerkrankungen – Eine neue Entität?

    Olliver Hoch, Rudolf A. Herbst, Ralf Gutzmer, Peter Kiehl, Alexander Kapp in Der Hautarzt (1998)

  13. No Access

    Article

    Das Bart-Syndrom – Eigene Entität oder Variante einer Epidermolysis bullosa?

    Ralf Gutzmer, Rudolf A. Herbst, Jost Becker, Peter Kiehl in Der Hautarzt (1997)

  14. No Access

    Article

    Das SAPHO-Syndrom Fallbeschreibung von drei Patienten mit Akne conglobata und osteoartikulären Symptomen

    Ralf Gutzmer, Rudolf A. Herbst, Alexander Kapp, Jürgen Weiß in Der Hautarzt (1997)

Page of 2 next disabled